New Chinese patent approval for Episurf Medical
Episurf Medical (NASDAQ: EPIS B) has received another Notice of Allowance from the Chinese patent office SIPO. The patent, entitled “System and method for optimising an implant position in an anatomical joint”, relates to Episurf Medical’s technology for design of the individualised Episealer® implants. "Optimised and efficient implant design is paramount in the production of Episurf Medical’s Episealer® implants, and we are happy for our inventions within that field”, comments Katarina Flodström, COO, Episurf Medical.